General Archive
-
News releasesTwo influential life science leaders join LifeArc science team
This quarter, we look forward to welcoming 2 new colleagues – Heather McKinnon and Giovanna Lalli – to strategic leadership…
-
News releases2023 wrapped: Our highlights from a successful year
As 2023 comes to a close, we reflect on another great year at LifeArc filled with, exciting partnerships and initiatives,…
-
News releasesLifeArc contributes to revitalisation of groundbreaking science education centre for children and young people
Centre of the Cell is the first informal science education centre in the world to be located within working biomedical…
-
Articles2022 wrapped – our highlights from a pivotal year
We’ve seen some exciting scientific progress, forged new partnerships and launched some new landmark initiatives.
-
News releases
LifeArc co-founded company RQ Bio signs licensing agreement with AstraZeneca worth up to $157m plus royalties for monoclonal antibodies against SARS-CoV-2
LONDON, UK, 17 May 2022 — LifeArc today announced that RQ Biotechnology Ltd (RQ Bio), a company it co-founded, has…